增强CT淋巴结短径及SCC-Ag在术前预测宫颈鳞癌淋巴结转移中的应用

Abstract
Figure/Table
References (28)
Related Citation (15)

Download: PDF (653 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application value of the shortest diameter of lymph nodes in enhanced CT and squamous cell carcinoma antigen (SCC-Ag) in diagnosing lymph node metastasis pre-operation in cervical squamous cell cancer. Methods Patients with cervical squamous cell carcinoma ⅠA1-ⅢCr stage who underwent radical cervical surgery in Beijing Obstetrics and Gynecology Hospital, Capital Medical University from October 2019 to December 2020 were selected. By single factor analysis and evaluation of the factors related to lymph node metastasis, the prediction model of lymph node metastasis was established and the predictive value of the model was evaluated. Results A total of 189 patients were included, including 30 in the lymph node metastasis group. There were statistically significant differences in maximum diameter, clinical stage, cell differentiation, preoperative serum SCC-AG and enhanced CT lymph node short diameter between the two groups (P ＜ 0.001), but there were no statistically significant differences in age and HPV infection (P ＞ 0.05). The best truncation value was 0.625cm, area under curve (AUC) value was 0.827 cm (P ＜ 0.001), sensitivity was 66.7%, and specificity was 83.0%, respectively. The optimal cut-off value of SCC-AG in predicting cervical squamous cell carcinoma lymph node metastasis was 1.88 ng/ml, AUC value was 0.733 (P ＜ 0.001), sensitivity was 66.7%, and specificity was 73.6%. The AUC value of the combined detection was 0.802 (P ＜ 0.001), the sensitivity was 66.7%, and the specificity was 84.3%. Conclusion SCC-Ag and the shortest diameter of lymph nodes in enhanced CT can be used to evaluate lymph node metastasis in patients with cervical squamous cell carcinoma,and the diagnostic value of the shortest diameter of lymph nodes in enhanced CT is higher,which provides a reference for clinical treatment planning.

Key words： Squamous cell carcinoma antigen Lymph node metastasis Squamous cell carcinoma antigen Enhanced CT Shortest diameter of lymph nodes

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIN Lin WU Yumei WANG Ming WEI Jiahui

Cite this article:

QIN Lin WU Yumei WANG Ming WEI Jiahui. Application of the shortest diameter of lymph nodes in enhanced CT and SCC-Ag predicting pre-operation lymph node metastasis in cervical squamous cell carcinoma#br#[J]. 中国医药导报, 2022, 19(5): 124-128.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I5/124

[1] Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin，2021，71（3）：209－249.
[2] Cohen PA，Jhingran A，Oaknin A，et al. Cervical cancer [J]. Lancet，2019，12，393（10167）：169－182.
[3] Khan SR，Rockall AG，Barwick TD. Molecular imaging in cervical cancer[J]. Q J Nucl Med Mol Imaging，2016，60（2）：77-92.
[4] Koh WJ，Abu-Rustum NR，Bean S，et al. Cervical Cancer,Version 3.2019，NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw，2019，17（1）：64-84.
[5] WHO Classification of tumours Editorial Board.Female Genital Tumours.WHO Classification of Tumours， 5th edition，vol.4 [M]. Lyon：IARC Press，2020：8.
[6] Aviel-Ronen S，Rubinek T，Zadok O，et al. Klotho expression in cervical cancer：differential expression in adenocarcinoma and squamous cell carcinoma [J]. J Clin Pathol，2016，69（1）：53-57.
[7] Matsuo K，Machida H，Mandelbaum RS，et al. Validation of the 2018 FIGO cervical cancer staging system [J]. Gynecol Oncol，2019，152（1）：87-93.
[8] 鲁琦，张震宇.国际妇产科联盟2018年版子宫颈癌分期标准的解读[J].中华妇产科杂志，2019，54（10）：718-720.
[9] Olawaiye AB，Baker TP，Washington MK，et al. The new（Version 9）American Joint Committee on Cancer tumor，node，metastasis staging for cervical cancer [J]. CA Cancer J Clin，2021，71（4）：287－298.
[10] Masri A，Steinmetz L，Robinson WR.Women with cervical carcinoma in pre-and post-katrina new orleans： a comparative analysis [J]. Gynecologic Oncology，2020，156：31-32.
[11] Yamada I，Oshima N，Wakabayashi A，et al. Diffusion-Tensor Imaging of Uterine Cervical Carcinoma： Correlation With Histopathologic Findings [J]. J Comput Assist Tomogr，2020，44（3）：426－435.
[12] Cibula D，P?觟tter R，Planchamp F，et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer [J]. Radiother Oncol，2018，127（3）：404－416.
[13] Plotti F，Messina G，Terranova C，et al. Sentinel lymph node in cervical cancer：a literature review on the use of conservative surgery techniques[J]. Minerva Ginecol，2020，72（6）：391-398.
[14] Bhatla N, Aoki D，Sharma DN，et al. Cancer of the cervix uteri [J]. Int J Gynaecol Obstet，2018，143 Suppl 2：22-36.
[15] Koh WJ，Abu－Rustum NR，Bean S，et al. Uterine Neoplasms，Version 1.2018，NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw，2018，16（2）：170-199.
[16] Kan Y，Dong D，Zhang Y，et al. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer [J]. J Magn Reson Imaging，2019， 49（1）：304-310.
[17] Herrera FG，Prior JO. The role of PET/CT in cervical cancer [J]. Front Oncol，2013，26，3：34.
[18] Jürgenliemk-Schulz IM, Beriwal S, de Leeuw AAC，et al.Management of Nodal Disease in Advanced Cervical Cancer [J]. Semin Radiat Oncol，2019，29（2）：158-165.
[19] 顾颖超，刘开江.PET-CT和PET-MRI在常见妇科恶性肿瘤诊治中的应用价值[J].中国实用妇科与产科杂志，2019，35（7）：839-843.
[20] Teymoortash A，Werner JA. Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer[J]. GMS Curr Top in Otorhinolaryngol Head Neck Surg，2012，11：Doc 04.
[21] 余莹莹，赵艳萍，周永，等.CT诊断早期宫颈癌淋巴结转移的价值[J].中国临床医学影像杂志，2016，27（8）：565－569.
[22] Jung W，Park KR，Lee KJ，et al. Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer [J]. Radiat Oncol J，2017，35（4）：340-348.
[23] Brunette LL，Bonyadlou S，Ji L，et al. Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer [J]. Clin Nucl Med，2018，43（11）：793-801.
[24] Tomassi MJ，Abbas MA，Klaristenfeld DD. Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus：a large US healthcare system experience[J]. Int J Colorectal Dis，2019，34（1）：47-54.
[25] Fu J，Wang W，Wang Y，et al. The role of squamous cell carcinoma antigen（SCC Ag）in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer[J]. Radiat Oncol， 2019，15，14（1）：146.
[26] Guo Q，Zhu J，Wu Y，et al. Predictive value of preoperative serum squamous cell carcinoma antigen（SCC-Ag）level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery：A single-institution study [J]. Eur J Surg Oncol，2020，46（1）：131-138.
[27] Xu D，Wang D，Wang S，et al. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis [J]. Int J Gynecol Cancer，2017，27（9）：1935-1942.
[28] 李丹，徐小仙，闫鼎鼎，等.早期宫颈鳞状细胞癌患者检测血清鳞状细胞癌抗原的临床意义[J].中华肿瘤杂志， 2019， 41（5）：357-362.